CD209 Antibody

ProSci
Product Code: PSI-79-703
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-79-703-0.1mg0.1mg£481.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Application: Western Blot (WB)
Storage:
Store antibody at -20˚C for up to one year.

Images

1 / 1
Western blot analysis of extract from JK, HUVEC, HepG2 and HeLa cells using CD209 (DC-SIGN).

Western blot analysis of extract from JK, HUVEC, HepG2 and HeLa cells using CD209 (DC-SIGN).

Further Information

Additional Names:
CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, RAF, CDSIGN
Application Note:
Western Blot: 1:500~1:1000
Background:
Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. Thought to mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. The receptor returns to the cell membrane surface and the pathogen-derived antigens are presented to resting T-cells via MHC class II proteins to initiate the adaptive immune response. Probably recognizes in a calcium-dependent manner high mannose N-linked oligosaccharides in a variety of pathogen antigens, including HIV-1 gp120, HIV-2 gp120, SIV gp120, ebolavirus glycoproteins, cytomegalovirus gB, HCV E2, dengue virus gE, Leishmania pifanoi LPG, Lewis-x antigen in Helicobacter pylori LPS, mannose in Klebsiella pneumonae LPS, di-mannose and tri-mannose in Mycobacterium tuberculosis ManLAM and Lewis-x antigen in Schistosoma mansoni SEA. On DCs it is a high affinity receptor for ICAM2 and ICAM3 by binding to mannose-like carbohydrates. May act as a DC rolling receptor that mediates transendothelial migration of DC presursors from blood to tissues by binding endothelial ICAM2. Seems to regulate DC-induced T-cell proliferation by binding to ICAM3 on T-cells in the immunological synapse formed between DC and T-cells.
Background References:
  • Geijtenbeek T. B. H., Kwon D. S., Torensma R., van Vliet S. J., van Duijnhoven G. C. F., Middel J., Cell 100:587-597 (2000) Geijtenbeek T. B. H., Krooshoop D. J., Bleijs D. A., van Vliet S. J., van Duijnhoven G. C. F., Grabovsky Nat. Immunol. 1:353-357 (2000) Engering A., Geijtenbeek T. B. H., van Vliet S. J., van Kooyk Y. J. Immunol. 168:2118-2126 (2002)
Buffer:
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
CD209 (DC-SIGN) antibody was raised against a peptide sequence around aa.389~393 ( E-Q-F-L-S ) derived from Human CD209 (DC-SIGN).
NCBI Gene ID #:
30835
NCBI Official Name:
CD209 molecule
NCBI Official Symbol:
CD209
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
46 kDa
Protein Accession #:
NP_066978.1
Protein GI Number:
10863957
Purification:
Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Research Area:
Other
SPECIFICITY:
This antibody detects endogenous level of total CD209 (DC-SIGN) protein.
Swissprot #:
Q9NNX6